Hyperfine Inc. ( (HYPR)) has released its Q3 earnings. Here is a breakdown of the information Hyperfine Inc. presented to its investors. Hyperfine, Inc. is a pioneering health technology company that ...

Despite a net loss, Hyperfine Inc (HYPR) showcases strong revenue growth, international expansion, and technological advancements.

GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared ...

Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago. These figures are adjusted for ...

Hyperfine Inc (NASDAQ:HYPR) is set to release its Q3 2024 earnings on Nov 12, 2024. The consensus estimate for Q3 2024 ...

Hyperfine, Inc. announced the presentation of additional research data and images using the Swoop® system to image patients ...

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first ...

医疗技术公司Hyperfine Inc. (HYPR)于2024年11月12日公布了第三季度财务业绩，展示了显著的收入增长和毛利率扩张。公司报告的收入为360万美元，同比增长56%，毛利率达到52%。 Hyperfine的增长主要由其Swoop便携式成像系统的强劲销售以及向新的医疗场所的扩张所推动。尽管增长积极，但公司在本季度仍录得1030万美元的净亏损。 要点摘要 第三季度收入同比增长56%至3 ...

英为财情Investing.com - Hyperfine (NASDAQ: HYPR )星期二发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益符合分析师的预期。 在该公司发布的最新财报中，公司每股收益为$-0.140，总营收为$3.64M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$3.3M，每股收益为$-0.140.

Hyperfine(HYPR)发布Q3财报，2024财年前三财季累计收入1056.90万美元，去年同期累计收入为834.60万美元，同比增长26.64%。 2024财年前三财季累计净亏损3033.00万美元，去年同期累计净亏损为3355.40万美元，同比缩小9.61%。 本财年累计基本每股收益为-0.42美元，去年同期为-0.47美元。 公司所属行业为医疗保健设备。 Hyperfine, Inc.

Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ETCompany ParticipantsMarissa Bych - Gilmartin GroupMaria Sainz ...